Abramson Cancer Center - University of Pennsylvania — Philadelphia, Pennsylvania

Abramson Cancer Center - University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center - University of Pennsylvania has participated in 2 clinical trials.

Therapeutic areas: Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Sponsors: Inhibrx Biosciences, Inc, Samus Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center - University of Pennsylvania?

Abramson Cancer Center - University of Pennsylvania has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center - University of Pennsylvania conducted?

Abramson Cancer Center - University of Pennsylvania has 2 clinical trials on record. Their work covers Metastatic Solid Tumors, Non-small Cell Lung Cancer, Melanoma.

Is Abramson Cancer Center - University of Pennsylvania accredited by Crixeo Health?

Abramson Cancer Center - University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center - University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.